1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Anti-Diabetic Drugs Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Biguanides
  • 1.2.3 Sulfonylureas
  • 1.2.4 Meglitinides
  • 1.2.5 Thiazolidinediones
  • 1.2.6 Dipeptidyl Peptidase IV Inhibitors
  • 1.2.7 α-Glucosidase Inhibitors
• 1.3 Market by Application
  • 1.3.1 Global Anti-Diabetic Drugs Market Share by Application: 2020 VS 2026
  • 1.3.2 Type I Diabetes
  • 1.3.3 Type II Diabetes
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Anti-Diabetic Drugs Market Perspective (2015-2026)
• 2.2 Global Anti-Diabetic Drugs Growth Trends by Regions
  • 2.2.1 Anti-Diabetic Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Anti-Diabetic Drugs Historic Market Share by Regions (2015-2020)
  • 2.2.3 Anti-Diabetic Drugs Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Anti-Diabetic Drugs Players by Market Size
  • 3.1.1 Global Top Anti-Diabetic Drugs Players by Revenue (2015-2020)
  • 3.1.2 Global Anti-Diabetic Drugs Revenue Market Share by Players (2015-2020)
• 3.2 Global Anti-Diabetic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Anti-Diabetic Drugs Revenue
• 3.4 Global Anti-Diabetic Drugs Market Concentration Ratio
  • 3.4.1 Global Anti-Diabetic Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Anti-Diabetic Drugs Revenue in 2019
• 3.5 Key Players Anti-Diabetic Drugs Area Served
• 3.6 Key Players Anti-Diabetic Drugs Product Solution and Service
• 3.7 Date of Enter into Anti-Diabetic Drugs Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-Diabetic Drugs Breakdown Data by Type (2015-2026)

• 4.1 Global Anti-Diabetic Drugs Historic Market Size by Type (2015-2020)
• 4.2 Global Anti-Diabetic Drugs Forecasted Market Size by Type (2021-2026)

5 Anti-Diabetic Drugs Breakdown Data by Application (2015-2026)

• 5.1 Global Anti-Diabetic Drugs Historic Market Size by Application (2015-2020)
• 5.2 Global Anti-Diabetic Drugs Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Anti-Diabetic Drugs Market Size (2015-2026)
• 6.2 North America Anti-Diabetic Drugs Market Size by Type (2015-2020)
• 6.3 North America Anti-Diabetic Drugs Market Size by Application (2015-2020)
• 6.4 North America Anti-Diabetic Drugs Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Anti-Diabetic Drugs Market Size (2015-2026)
• 7.2 Europe Anti-Diabetic Drugs Market Size by Type (2015-2020)
• 7.3 Europe Anti-Diabetic Drugs Market Size by Application (2015-2020)
• 7.4 Europe Anti-Diabetic Drugs Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Anti-Diabetic Drugs Market Size (2015-2026)
• 8.2 China Anti-Diabetic Drugs Market Size by Type (2015-2020)
• 8.3 China Anti-Diabetic Drugs Market Size by Application (2015-2020)
• 8.4 China Anti-Diabetic Drugs Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Anti-Diabetic Drugs Market Size (2015-2026)
• 9.2 Japan Anti-Diabetic Drugs Market Size by Type (2015-2020)
• 9.3 Japan Anti-Diabetic Drugs Market Size by Application (2015-2020)
• 9.4 Japan Anti-Diabetic Drugs Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Anti-Diabetic Drugs Market Size (2015-2026)
• 10.2 Southeast Asia Anti-Diabetic Drugs Market Size by Type (2015-2020)
• 10.3 Southeast Asia Anti-Diabetic Drugs Market Size by Application (2015-2020)
• 10.4 Southeast Asia Anti-Diabetic Drugs Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Astra Zeneca
  • 11.1.1 Astra Zeneca Company Details
  • 11.1.2 Astra Zeneca Business Overview
  • 11.1.3 Astra Zeneca Anti-Diabetic Drugs Introduction
  • 11.1.4 Astra Zeneca Revenue in Anti-Diabetic Drugs Business (2015-2020))
  • 11.1.5 Astra Zeneca Recent Development
• 11.2 Boehringer Ingelheim
  • 11.2.1 Boehringer Ingelheim Company Details
  • 11.2.2 Boehringer Ingelheim Business Overview
  • 11.2.3 Boehringer Ingelheim Anti-Diabetic Drugs Introduction
  • 11.2.4 Boehringer Ingelheim Revenue in Anti-Diabetic Drugs Business (2015-2020)
  • 11.2.5 Boehringer Ingelheim Recent Development
• 11.3 Eli Lilly
  • 11.3.1 Eli Lilly Company Details
  • 11.3.2 Eli Lilly Business Overview
  • 11.3.3 Eli Lilly Anti-Diabetic Drugs Introduction
  • 11.3.4 Eli Lilly Revenue in Anti-Diabetic Drugs Business (2015-2020)
  • 11.3.5 Eli Lilly Recent Development
• 11.4 Johnson & Johnson
  • 11.4.1 Johnson & Johnson Company Details
  • 11.4.2 Johnson & Johnson Business Overview
  • 11.4.3 Johnson & Johnson Anti-Diabetic Drugs Introduction
  • 11.4.4 Johnson & Johnson Revenue in Anti-Diabetic Drugs Business (2015-2020)
  • 11.4.5 Johnson & Johnson Recent Development
• 11.5 Merck
  • 11.5.1 Merck Company Details
  • 11.5.2 Merck Business Overview
  • 11.5.3 Merck Anti-Diabetic Drugs Introduction
  • 11.5.4 Merck Revenue in Anti-Diabetic Drugs Business (2015-2020)
  • 11.5.5 Merck Recent Development
• 11.6 Novartis
  • 11.6.1 Novartis Company Details
  • 11.6.2 Novartis Business Overview
  • 11.6.3 Novartis Anti-Diabetic Drugs Introduction
  • 11.6.4 Novartis Revenue in Anti-Diabetic Drugs Business (2015-2020)
  • 11.6.5 Novartis Recent Development
• 11.7 Novo Nordisk
  • 11.7.1 Novo Nordisk Company Details
  • 11.7.2 Novo Nordisk Business Overview
  • 11.7.3 Novo Nordisk Anti-Diabetic Drugs Introduction
  • 11.7.4 Novo Nordisk Revenue in Anti-Diabetic Drugs Business (2015-2020)
  • 11.7.5 Novo Nordisk Recent Development
• 11.8 Sanofi
  • 11.8.1 Sanofi Company Details
  • 11.8.2 Sanofi Business Overview
  • 11.8.3 Sanofi Anti-Diabetic Drugs Introduction
  • 11.8.4 Sanofi Revenue in Anti-Diabetic Drugs Business (2015-2020)
  • 11.8.5 Sanofi Recent Development
• 11.9 Teva Pharmaceutical Industries
  • 11.9.1 Teva Pharmaceutical Industries Company Details
  • 11.9.2 Teva Pharmaceutical Industries Business Overview
  • 11.9.3 Teva Pharmaceutical Industries Anti-Diabetic Drugs Introduction
  • 11.9.4 Teva Pharmaceutical Industries Revenue in Anti-Diabetic Drugs Business (2015-2020)
  • 11.9.5 Teva Pharmaceutical Industries Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Anti-Diabetic Drugs Scope and Market Size
Anti-Diabetic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Diabetic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Biguanides
Sulfonylureas
Meglitinides
Thiazolidinediones
Dipeptidyl Peptidase IV Inhibitors
α-Glucosidase Inhibitors

Market segment by Application, split into
Type I Diabetes
Type II Diabetes
Others

Based on regional and country-level analysis, the Anti-Diabetic Drugs market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Anti-Diabetic Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Astra Zeneca
Boehringer Ingelheim
Eli Lilly
Johnson & Johnson
Merck
Novartis
Novo Nordisk
Sanofi
Teva Pharmaceutical Industries